Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL

(MedPage Today) -- Prophylaxis with apixaban (Eliquis) failed to reduce the rate of venous thromboembolism (VTE) in children with newly diagnosed acute lymphoblastic leukemia or lymphoma, according to results from the phase III randomized PREVAPIX...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news